Track the 쓰리빌리언 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 쓰리빌리언 has published 1 reports. Market capitalisation: €153.4bn. The latest transaction was filed on 1 April 2026 (Purchase). Among the most active insiders: 국민연금공단. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
쓰리빌리언 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para mejorar la salud del paciente.